[ESPR] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -21.74%
YoY- -13.79%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 7,978 1,840 145,419 0 0 0 0 -
PBT -90,935 -78,249 87,379 -46,130 -40,541 -14,585 -11,466 41.17%
Tax 8,139 4,539 0 0 482 457 227 81.49%
NP -90,935 -78,249 87,379 -46,130 -40,541 -14,585 -11,466 41.17%
Tax Rate - - 0.00% - - - - -
Total Cost 98,913 80,089 58,040 46,130 40,541 14,585 11,466 43.16%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -1,139.82 -4,252.66 60.09 0.00 0.00 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -3.50 -2.84 3.26 -1.73 -1.80 -0.65 -0.56 35.68%
EPS Diluted -3.50 -2.84 3.07 -1.73 -1.80 -0.65 -0.56 35.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.